Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...

Investing.com - Nvidia (NASDAQ:NVDA) is "well-positioned" to capture most of the expected growth in the market for specialized artificial intelligence-enhancing hardware in 2025, analysts at Piper ...

Fintel reports that on November 8, 2024, Piper Sandler upgraded their outlook for Upstart Holdings (NasdaqGS:UPST) from ...

SolarEdge Technologies rebounds after Trump administration fears, but Q3 loss and forecasted revenue decline raise concerns.

Piper Sandler raised the firm’s price target on Amplitude (AMPL) to $11 from $9 and keeps a Neutral rating on the shares. The firm said ...

In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on Solid Biosciences (SLDB – Research Report), with a ...

Expectations for President-elect Donald Trump to roll out expansionary fiscal policies and extend U.S. economic ...

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

Celanese downgraded at Piper Sandler, citing uncertain business environment and financial strain ahead with a precarious condition of the balance sheet.

Piper Sandler initiates coverage of Nektar Therapeutics, citing REZPEG's Treg-focused action as a potential breakthrough for ...

Piper Sandler Companies (NYSE:PIPR – Get Free Report) last issued its quarterly earnings data on Friday, October 25th.The financial services provider reported $2.57 earnings per share for the ...

On Tuesday, Piper Sandler began coverage of CAMP4 Therapeutics Corp (NASDAQ:CAMP) stock with an Overweight rating and a price target of $18.00. The firm highlighted CAMP4's innovative work in the ...